Esperion Therapeutics Stock Market Value
| ESPR Stock | USD 2.54 0.03 1.17% |
| Symbol | Esperion |
Esperion Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share 1.776 | Quarterly Revenue Growth 0.52 | Return On Assets 0.0384 | Return On Equity (2.61) |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Esperion Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Esperion Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Esperion Therapeutics.
| 09/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Esperion Therapeutics on September 29, 2024 and sell it all today you would earn a total of 0.00 from holding Esperion Therapeutics or generate 0.0% return on investment in Esperion Therapeutics over 60 days. Esperion Therapeutics is related to or competes with Elanco Animal, SIGA Technologies, Catalent, ANI Pharmaceuticals, Phibro Animal, Prestige Brand, and Collegium Pharmaceutical. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patien... More
Esperion Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Esperion Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Esperion Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.03 | |||
| Information Ratio | 0.1267 | |||
| Maximum Drawdown | 21.27 | |||
| Value At Risk | (5.83) | |||
| Potential Upside | 10.2 |
Esperion Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Esperion Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Esperion Therapeutics' standard deviation. In reality, there are many statistical measures that can use Esperion Therapeutics historical prices to predict the future Esperion Therapeutics' volatility.| Risk Adjusted Performance | 0.1265 | |||
| Jensen Alpha | 0.4644 | |||
| Total Risk Alpha | 0.0069 | |||
| Sortino Ratio | 0.1427 | |||
| Treynor Ratio | 0.3522 |
Esperion Therapeutics Backtested Returns
Esperion Therapeutics appears to be relatively risky, given 3 months investment horizon. Esperion Therapeutics secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14% return per unit of risk over the last 3 months. By reviewing Esperion Therapeutics' technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please utilize Esperion Therapeutics' Coefficient Of Variation of 648.14, mean deviation of 3.36, and Downside Deviation of 4.03 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Esperion Therapeutics holds a performance score of 10. The firm shows a Beta (market volatility) of 1.96, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Esperion Therapeutics will likely underperform. Please check Esperion Therapeutics' value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Esperion Therapeutics' price patterns will revert.
Auto-correlation | 0.37 |
Below average predictability
Esperion Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Esperion Therapeutics time series from 29th of September 2024 to 29th of October 2024 and 29th of October 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Esperion Therapeutics price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Esperion Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Esperion Therapeutics lagged returns against current returns
Autocorrelation, which is Esperion Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Esperion Therapeutics' stock expected returns. We can calculate the autocorrelation of Esperion Therapeutics returns to help us make a trade decision. For example, suppose you find that Esperion Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Esperion Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Esperion Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Esperion Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Esperion Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Esperion Therapeutics Lagged Returns
When evaluating Esperion Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Esperion Therapeutics stock have on its future price. Esperion Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Esperion Therapeutics autocorrelation shows the relationship between Esperion Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Esperion Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Esperion Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Esperion Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Esperion Stock
| 0.9 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
Moving against Esperion Stock
| 0.84 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.82 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.77 | PEPG | PepGen | PairCorr |
| 0.72 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.72 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Esperion Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Esperion Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Esperion Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Esperion Therapeutics to buy it.
The correlation of Esperion Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Esperion Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Esperion Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Esperion Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.